Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria | Aplastic Anemia & MDS International Foundation Return to top.
  1. Education
  2. Research Articles
  3. Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria

Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria

Journal Title: 
Am J Hematol
Primary Author: 
Hillmen P
Author(s): 
Hillmen P, Muus P, Szer J, Hill A, Höchsmann B, Kulasekararaj A, Risitano AM, Van Den Neste E, Liljeholm M, Ebrahim KS, Bedrosian CL, Gao X, Ames D, Socié G
Original Publication Date: 
Monday, December 21, 2015

No abstract available.

Bone Marrow Disease(s): 
  • paroxysmal nocturnal hemoglobinuria (PNH)
Share with addtoany.com.